+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market - Global Forecast 2025-2030- Product Image
Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market - Global Forecast 2025-2030- Product Image
Sale

Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6139413
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

AI-driven cardiovascular and cerebrovascular diagnostic solutions are rapidly redefining clinical pathways, equipping senior healthcare leaders with efficient, accurate, and scalable imaging capabilities. As these technologies mature, decision-makers are facing new choices in vendor partnerships, integration approaches, and strategic investments that impact patient outcomes and operational resilience.

Market Snapshot: AI-Driven Cardiovascular and Cerebrovascular Diagnostic Solutions

The global market for AI-driven cardiovascular and cerebrovascular diagnostic solutions is evolving in response to heightened demand for rapid and precise diagnostics. Integrated platforms now combine advanced image processing, deep learning algorithms, and multi-modal data to streamline detection of conditions across both cardiology and neurovascular care. Industry leaders are investing in research, technology partnerships, and regional expansion to drive adoption, while operational and regulatory shifts are influencing deployment strategies.

Scope & Segmentation

This report offers strategic insights into the full scope of AI-enabled cardiovascular and cerebrovascular diagnostics, mapping the landscape across application, technology, components, user settings, deployment modes, regional trends, and key vendor activity.

  • Applications: Arrhythmia detection (atrial fibrillation, ventricular tachycardia), heart disease diagnosis (coronary artery disease, valvular heart disease), and stroke detection (hemorrhagic and ischemic).
  • Components: Hardware (such as computed tomography, magnetic resonance imaging, ultrasound imaging), software innovations (deep learning, image processing, machine learning), and full-spectrum services (consulting, support, training).
  • End Users: Ambulatory centers (clinics, home healthcare), diagnostic centers (network, stand-alone), hospitals (private, public).
  • Deployment Modes: Cloud models (hybrid, private, public), on-premise approaches (integrated infrastructure, standalone server).
  • Geographies: Americas (including the United States, Canada, Mexico, Brazil, Argentina), EMEA (UK, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, HeartFlow, Inc., Zebra Medical Vision Ltd., Arterys, Inc., Viz.ai, Inc., Aidoc Medical Ltd., Caption Health, Inc.

Key Takeaways for Senior Decision-Makers

  • AI-driven cardiovascular and cerebrovascular diagnostic solutions offer faster, more consistent results and reduce reliance on manual clinical review, accelerating time-sensitive interventions.
  • Algorithmic advancements and imaging hardware innovation, combined with cloud and edge computing, are enabling flexible deployments across hospitals, ambulatory, and even home care settings.
  • Strategic partnerships among device manufacturers, software firms, and research organizations are resulting in bundled offerings that streamline procurement and integration efforts for health systems.
  • Growing adoption in the United States and Canada is driven by stable reimbursement frameworks, while emerging markets in EMEA and Asia-Pacific are leveraging cloud-native infrastructures and targeted public sector investment.
  • Industry leaders are advancing modular, explainable AI platforms to help clinicians easily interpret results and institutions maintain compliance with evolving regulatory and data privacy requirements.

Tariff Impact

In 2025, revised United States tariffs on imported imaging components are increasing procurement complexities and costs for both vendors and healthcare providers. Organizations are responding through regionalized manufacturing and exploring subscription-based licensing models. As a result, supply chains are being restructured, and cloud-based deployments are gaining traction to mitigate CapEx pressures.

Research Methodology & Data Sources

This analysis synthesizes insights from primary interviews with clinical leaders and administrators, combined with extensive review of peer-reviewed literature, regulatory documents, and vendor briefings. Analytical frameworks such as PESTLE and SWOT ensure findings are robust, consistent, and relevant to executive needs.

Why This Report Matters

  • Empowers senior leaders to make informed decisions on AI-driven cardiovascular and cerebrovascular diagnostics integration and investment.
  • Highlights evolving vendor strategies, regulatory trends, and regional differences that impact go-to-market strategies and clinical ROI.
  • Enables benchmarking of organizational readiness, procurement planning, and partnership evaluation based on actionable insights.

Conclusion

AI-based diagnostic solutions are reshaping management strategies in cardiovascular and cerebrovascular care. Forward-looking decision-makers will leverage these insights to navigate regulatory shifts, supplier dynamics, and technology integration for sustained clinical and operational value.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of deep learning algorithms for real-time stroke detection in neuroimaging workflows
5.2. Adoption of cloud-based multimodal imaging platforms to enhance AI-driven cardiac risk stratification
5.3. Development of explainable AI frameworks to increase clinician trust in cerebrovascular diagnostics
5.4. Implementation of federated learning protocols to protect patient data across hospital networks
5.5. Emergence of AI-powered wearable sensors for continuous monitoring of cardiac arrhythmias in outpatient settings
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market, by Application
8.1. Introduction
8.2. Arrhythmia Detection
8.2.1. Atrial Fibrillation
8.2.2. Ventricular Tachycardia
8.3. Heart Disease
8.3.1. Coronary Artery Disease
8.3.2. Valvular Heart Disease
8.4. Stroke Detection
8.4.1. Hemorrhagic Stroke
8.4.2. Ischemic Stroke
9. Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market, by Component
9.1. Introduction
9.2. Hardware
9.2.1. Computed Tomography
9.2.2. Magnetic Resonance Imaging
9.2.3. Ultrasound Imaging
9.3. Services
9.3.1. Consulting
9.3.2. Support
9.3.3. Training
9.4. Software
9.4.1. Deep Learning
9.4.2. Image Processing
9.4.3. Machine Learning
10. Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market, by End User
10.1. Introduction
10.2. Ambulatory Centers
10.2.1. Clinics
10.2.2. Home Healthcare
10.3. Diagnostic Centers
10.3.1. Network Centers
10.3.2. Stand-Alone Centers
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market, by Deployment Mode
11.1. Introduction
11.2. Cloud
11.2.1. Hybrid Cloud
11.2.2. Private Cloud
11.2.3. Public Cloud
11.3. On-Premise
11.3.1. Integrated Infrastructure
11.3.2. Standalone Server
12. Americas Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Siemens Healthineers AG
15.3.2. GE HealthCare Technologies Inc.
15.3.3. Koninklijke Philips N.V.
15.3.4. Canon Medical Systems Corporation
15.3.5. HeartFlow, Inc.
15.3.6. Zebra Medical Vision Ltd.
15.3.7. Arterys, Inc.
15.3.8. Viz.ai, Inc.
15.3.9. Aidoc Medical Ltd.
15.3.10. Caption Health, Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET: RESEARCHAI
FIGURE 24. CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET: RESEARCHSTATISTICS
FIGURE 25. CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET: RESEARCHCONTACTS
FIGURE 26. CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY VENTRICULAR TACHYCARDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY VENTRICULAR TACHYCARDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY VALVULAR HEART DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY VALVULAR HEART DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY TRAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY NETWORK CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY NETWORK CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STAND-ALONE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STAND-ALONE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY INTEGRATED INFRASTRUCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY INTEGRATED INFRASTRUCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STANDALONE SERVER, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STANDALONE SERVER, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 177. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2018-2024 (USD MILLION)
TABLE 180. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2025-2030 (USD MILLION)
TABLE 181. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2018-2024 (USD MILLION)
TABLE 182. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2025-2030 (USD MILLION)
TABLE 183. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2018-2024 (USD MILLION)
TABLE 184. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2025-2030 (USD MILLION)
TABLE 185. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 186. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 187. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 188. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 189. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 190. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 191. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 192. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 193. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2018-2024 (USD MILLION)
TABLE 196. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2025-2030 (USD MILLION)
TABLE 197. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 198. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 199. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 200. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 201. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 202. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 203. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 204. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 205. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, 2018-2024 (USD MILLION)
TABLE 206. CANADA CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ON-PREMISE, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY ARRHYTHMIA DETECTION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HEART DISEASE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2018-2024 (USD MILLION)
TABLE 214. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY STROKE DETECTION, 2025-2030 (USD MILLION)
TABLE 215. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 216. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 217. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 220. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 221. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2018-2024 (USD MILLION)
TABLE 226. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY AMBULATORY CENTERS, 2025-2030 (USD MILLION)
TABLE 227. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 228. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 229. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 230. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 234. MEXICO CARDIOVASCULAR & CEREBROVASCULAR AI-ASSISTED DIAGNOSIS SOLUTION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cardiovascular & Cerebrovascular AI-assisted Diagnosis Solution Market report include:
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • HeartFlow, Inc.
  • Zebra Medical Vision Ltd.
  • Arterys, Inc.
  • Viz.ai, Inc.
  • Aidoc Medical Ltd.
  • Caption Health, Inc.

Related Topics

Related Reports

AI Medical Imaging Software for Acute Cerebrovascular Disease Market - Global Forecast 2025-2030 - Product Image

AI Medical Imaging Software for Acute Cerebrovascular Disease Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2025-2030 - Product Image

AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Cardiac AI Monitoring and Diagnostics Market Report 2025 - Product Image

Cardiac AI Monitoring and Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Artificial Intelligence (AI)-assisted Radiology - Global Strategic Business Report - Product Image

Artificial Intelligence (AI)-assisted Radiology - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Artificial Intelligence in Cardiology - Global Strategic Business Report - Product Image

Artificial Intelligence in Cardiology - Global Strategic Business Report

  • Report
  • 172 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.